HC Wainwright reiterated their buy rating on shares of Daré Bioscience (NASDAQ:DARE – Free Report) in a report published on Wednesday morning, Benzinga reports. They currently have a $6.00 price objective on the biotechnology company’s stock. A number of other research analysts also recently issued reports on the stock. Dawson James downgraded shares of Daré […]
Daré Bioscience (NASDAQ:DARE – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a report released on Wednesday, Benzinga reports. They currently have a $6.00 price target on the biotechnology company’s stock. Several other research analysts have also weighed in on the stock. Dawson James lowered shares of […]
Daré Bioscience (NASDAQ:DARE – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a research report issued on Monday, Benzinga reports. They presently have a $6.00 price objective on the biotechnology company’s stock. HC Wainwright also issued estimates for Daré Bioscience’s FY2025 earnings at $0.10 EPS, FY2026 earnings […]
Daré Bioscience, Inc. (NASDAQ:DARE – Get Free Report) was the recipient of a large increase in short interest in December. As of December 15th, there was short interest totalling 979,200 shares, an increase of 76.8% from the November 30th total of 553,900 shares. Based on an average daily volume of 494,500 shares, the days-to-cover ratio […]
Daré Bioscience, Inc. (NASDAQ:DARE – Get Free Report) passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.42 and traded as low as $0.33. Daré Bioscience shares last traded at $0.34, with a volume of 233,070 shares changing hands. Analysts Set New Price […]